Gao Kun, Chen Zujian, Zhang Na, Jiang Pu
Thoracic Surgery Department, Fourth Hospital of Hebei Medical University, No.12 Jiankang Road, Shijiazhuang City, Hebei Province 050000, China.
Thoracic Surgery Department, Linxi County People's Hospital, Xingtai City Linxi County People's Hospital New Campus 054900, China.
Saudi Pharm J. 2024 Sep;32(9):102139. doi: 10.1016/j.jsps.2024.102139. Epub 2024 Jul 6.
Lung cancer ranks as the 2nd most common cancer globally. It's the most prevalent cancer in men and the 2nd most common in women. The prominent events in EGFR-mutated non-small-cell lung cancer (NSCLC) include the emergence of the L858R mutation within EGFR exon 21. Despite the promising efficacy of EGFR inhibitors in managing lung cancer, the development of acquired resistance poses a significant hurdle. In the current investigation, we focused on the screening of two phytochemicals, namely Dehydrocostus lactone and Mokkolactone, derived from the plant, as potential inhibitors targeting EGFR L858R mutant lung cancer. The chloroform and ethanol extract of the plant demonstrated anti-proliferative activity through the Resazurin chemosensitivity assay, exhibiting an IC50 value of 37.90 ± 0.29 µg/ml with selectivity index 2.4. Through a GC-MS study, we identified 11 phytochemicals for further analysis. These compounds underwent ADMET assessment followed by drug likeliness analysis before being subjected to molecular docking against EGFR L858R, identified through protein-protein interaction network analysis. All phytochemicals exhibited binding energy scores ranging from -6.9 to -8.1 kcal/mol. Dehydrocostus lactone and Mokkolactone were specifically identified for their binding profile. Findings from 100 ns molecular dynamics simulations demonstrated their enhanced stability compared to the reference ligand DJK. This was evident in the root mean square deviation (RMSD) values, ranging from 0.23 ± 0.01 nm to 0.30 ± 0.05 nm, the radius of gyration values, from 1.71 ± 0.01 nm to 1.72 ± 0.01 nm, and the solvent accessible surface area values, from 155.39 ± 2.40 nm to 159.32 ± 2.14 nm. Additionally, favourable characteristics were observed in terms of hydrogen bonding, principal component analysis, and free energy landscape analysis. Examination of their electronic structure via density functional theory revealed efficient properties, with the highest occupied molecular orbital-least unoccupied molecular orbital energy gap values ranging from -3.984 eV to -6.547 eV. Further, in vivo analysis is required to gain a more comprehensive understanding and efficacy of these identified phytochemicals against lung cancer.
肺癌是全球第二大常见癌症。它是男性中最普遍的癌症,在女性中是第二大常见癌症。表皮生长因子受体(EGFR)突变的非小细胞肺癌(NSCLC)中的突出事件包括EGFR第21外显子内L858R突变的出现。尽管EGFR抑制剂在治疗肺癌方面疗效显著,但获得性耐药的出现构成了重大障碍。在当前的研究中,我们专注于筛选两种从植物中提取的植物化学物质,即脱氢木香内酯和莫克内酯,作为靶向EGFR L858R突变肺癌的潜在抑制剂。该植物的氯仿和乙醇提取物通过刃天青化学敏感性试验显示出抗增殖活性,IC50值为37.90±0.29µg/ml,选择性指数为2.4。通过气相色谱-质谱联用(GC-MS)研究,我们鉴定出11种植物化学物质用于进一步分析。这些化合物在通过蛋白质-蛋白质相互作用网络分析鉴定出EGFR L858R后,先进行了药物代谢动力学(ADMET)评估,然后进行药物相似性分析,之后再进行分子对接。所有植物化学物质的结合能分数在-6.9至-8.1千卡/摩尔之间。脱氢木香内酯和莫克内酯因其结合模式而被特别鉴定出来。100纳秒分子动力学模拟的结果表明,与参考配体DJK相比,它们具有更高的稳定性。这在均方根偏差(RMSD)值(范围为0.23±0.01纳米至0.30±0.05纳米)、回转半径值(范围为1.71±0.01纳米至1.72±0.01纳米)和溶剂可及表面积值(范围为155.39±2.40纳米至159.32±2.14纳米)中很明显。此外,在氢键、主成分分析和自由能景观分析方面也观察到了有利的特征。通过密度泛函理论对其电子结构进行研究,发现其具有有效的性质,最高占据分子轨道-最低未占据分子轨道能隙值在-3.984电子伏特至-6.547电子伏特之间。此外,需要进行体内分析,以更全面地了解这些已鉴定的植物化学物质对肺癌的疗效。